24 août 2026
Aton Group has fully redeemed the outstanding ORAs subscribed by Iris Capital under its 2021 financing facility, which provided approximately €11 million to support the Group’s restructuring and development.
Illkirch, 24 August 2026 – Aton Group, a specialist in life sciences and medical technologies, announces that, as of today, it has fully redeemed the outstanding redeemable bonds in shares (ORAs) issued under its financing facility subscribed by Iris Capital and established in 2021.
This facility has been one of the pillars of the Group’s financing over recent years, enabling it to raise approximately €11 million out of a maximum contractual capacity of €50 million, supporting the Group’s restructuring, development and the acceleration of its expansion, particularly in diagnostic technologies.
Download ATON Press Release (in French)